Skip to main content
Caplight Logo









Austrianova

Austrianova

Private
SingaporeHealthcare & Life Scienceshttps://austrianova.com/

Last Round

VC Round

Mar 1, 2023

Company Overview

Austrianova is a biotechnology company that provides cell encapsulation technology and services for the development of novel therapies and products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

cell encapsulationbiotechnologylive cell deliverycell therapydrug delivery systemmicrobiome therapeuticsregenerative medicinefill and finishcell bankingGMP manufacturingbiotech CDMObio-encapsulationcell line developmenttherapeutic deliverybiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Austrianova Comparables

Compare Austrianova with similar companies based on industry and business-model similarity.

Austrianova comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ALTuCELL
80%
Vicapsys Life Sciences Inc
77%
Encellin
76%

Austrianova Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 1, 2023
VC RoundJul 7, 2021
Post-IPO Equity FacilityApr 22, 2021
VC RoundMay 21, 2007

Key People

Founding team and executive leadership

Brian Salmons

CEO

Executive Team

Pierre Faddoul

Chief Financial Officer

Executive Team

Austrianova Investors

Notable investors and investment history

Austrianova investors
InvestorRounds
Global Emerging MarketsPost-IPO Equity Facility
Checkmate CapitalVC Round
Ryan Group HoldingsVC Round
UntroD Capital Japan Inc.VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 19, 2025

    Klothonova formed to develop klotho-based cell therapies.

  • Sep 19, 2025

    Partnered with Avant Technologies to form Klothonova.

Recent news

Latest coverage and updates

  • attends_eventSep 24, 2026

    Austrianova attended event Second Annual Klotho Conference on Sep 18th '26.

Austrianova Filings

Explore SEC and related filing metadata, where available.

Austrianova filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Austrianova's valuation, stock price, and market status.

Is Austrianova a public or private company?

Austrianova is a private company.

What is the current stock price of Austrianova?

Austrianova is a private company with no public stock price. No recent secondary market data is available.

How much is Austrianova worth (valuation)?

Valuation information for Austrianova is not publicly available.

Can I buy Austrianova stock?

Austrianova shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Austrianova's last funding round?

Austrianova's most recent funding round was VC Round on March 1, 2023.

Who are the main investors in Austrianova?

Key investors in Austrianova include Global Emerging Markets, Checkmate Capital, Ryan Group Holdings, UntroD Capital Japan Inc..

Will Austrianova IPO soon?

No public IPO plans have been announced for Austrianova.

How can I track Austrianova secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Austrianova's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range11
Year Founded2007
Last FundingMar 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?